Skip to main content

TYVASO is approved for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve the ability to exercise.

Skip to main content
Hamburger button
Close button


For more information about TYVASO, please use the contact information below:

Questions about TYVASO or United Therapeutics?

Call 1-877-UNITHER (1-877-864-8437).

Receive updates and information from the TYVASO Support Program.